| NCT ID | NCT06737289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Complutense de Madrid |
| Condition | Atrophic Maxilla |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-12-11 |
| Primary Completion | 2025-06-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-12-11 with a primary completion date of 2025-06-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of zygomatic implants is a technique that is becoming more and more widespread in daily clinical practice, however, few professionals feel safe and confident in performing this type of procedure. We therefore believe that a line of research focused on simplifying this technique will have an extraordinary impact on the safety of both patients and surgeons. Currently, new surgical guides have emerged that guarantee greater precision in the placement of zygomatic implants. However, no comparative clinical studies have yet been performed to evaluate the degree of accuracy of guided implant placement compared to the conventional freehand technique.
Eligibility Criteria
Inclusion Criteria: • Age between 18-80 years of age, patients who sign the informed consent form and patients who consent to undergo preoperative and postoperative orthopantomography and CT scans. Exclusion Criteria: * Smoking (more than 10 cigarettes per day). * Alcoholism (more than 25g/day in women and more than 40g/day in men according to WHO criteria), * Oncological treatment (history of treatment in the last 6 months or current treatment with chemotherapy or radiotherapy). * History of head and neck radiotherapy. * Allergic to anesthetics or antibiotics.
Contact & Investigator
JEsus Torres, PhD
PRINCIPAL INVESTIGATOR
UCM
Frequently Asked Questions
Who can join the NCT06737289 clinical trial?
This trial is open to participants of all sexes, studying Atrophic Maxilla. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06737289 currently recruiting?
Yes, NCT06737289 is actively recruiting participants. Contact the research team at jesus.torres@ucm.es for enrollment information.
Where is the NCT06737289 trial being conducted?
This trial is being conducted at Madrid, Spain, Madrid, Spain.
Who is sponsoring the NCT06737289 clinical trial?
NCT06737289 is sponsored by Universidad Complutense de Madrid. The principal investigator is JEsus Torres, PhD at UCM. The trial plans to enroll 20 participants.